Silence Therapeutics plc Profit Loss Before Tax
Silence Therapeutics plc (SLN) reported Profit Loss Before Tax of -GBP 50.31 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2024-03-13
| Period end | Profit Loss Before Tax 12 month |
|---|---|
| 2023-12-31 | -50.31M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | -47.37M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | -45.86M GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | -36.04M GBP 20-F · filed 2023-03-15 |
| 2019-12-31 | -22.87M GBP 20-F · filed 2022-03-17 |
| 2018-12-31 | -20.53M GBP 20-F/A · filed 2021-04-29 |